Interactions between NSAIDs and Alcohol in the Context of Clinical Practice – A Review of Studies
DOI:
https://doi.org/10.12775/QS.2025.39.59243Keywords
non-steroidal anti-inflammatory drugs, COX-1, COX-2, alcoholAbstract
Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used pharmacological agents with potent anti-inflammatory, analgesic, and antipyretic properties. Due to their broad application and availability, both prescription and over-the-counter, NSAIDs are highly popular across various age groups. Millions of people worldwide use these medications daily, making them one of the most commonly utilized drugs.
On the other hand, ethanol, one of the most widely consumed psychoactive substances, is widely ingested globally. Both alcohol and NSAIDs undergo complex pharmacokinetic processes, including absorption, distribution, metabolism, and elimination. The co-existence of these substances in the body can lead to significant interactions that affect the efficacy of therapy and increase the risk of adverse effects.
The objective of this study is to review the literature concerning interactions between NSAIDs and alcohol, with a particular emphasis on the impact of these interactions on usage practices and health outcomes. The study discusses the mechanisms of action of both substances, their effects on the gastrointestinal system, liver, and other organs, as well as the potential risks associated with their concurrent use.
Aim of study: The aim of this study is to summarize the available knowledge about how alcohol influence on metabolism of non-steroidal anti-inflammatory drugs in human. Particular emphasis has been placed on its impact on the gastrointestinal, renal, and cardiovascular systems, which have been thoroughly analyzed and summarized.
Material and methods: The literature available in PubMed, and the Google Scholar database was reviewed using the following keywords: ,,non-steroidal anti-inflammatory drugs”, ,,alcohol”, ,,COX-1”, ,,COX-2”
References
[1] Gøtzsche PC. Non-steroidal anti-inflammatory drugs. BMJ. 2000 Apr 15;320(7241):1058-61. PMID: 10764369; PMCID: PMC1117944 doi: 10.1136/bmj.320.7241.1058.
[2] Brune, K., & Patrignani, P. (2015). New insights into the use of currently available non-steroidal anti-inflammatory drugs, Journal of Pain Research, 105–118. https://doi.org/10.2147/JPR.S75160
[3] Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Antiinflamm Antiallergy Agents Med Chem. 2012;11(1):52-64. doi: 10.2174/187152312803476255. PMID: 22934743.
[4] Inger L. Meek, Mart A.F.J. van de Laar and Harald E. Vonkeman; Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks, Pharmaceuticals 2010, 3, 2146-2162; doi:10.3390/ph3072146
[5] Joanna Synoweć, Katarzyna Pogorzelczyk, Marlena Robakowska, Daniel Ślęzak, Przemysław Żuratyński, Klaudiusz Nadolny, Wioletta Mędrzycka-Dąbrowska. The consequences of using widely available non-steroidal anti-inflammatory drugs (NSAIDs), DOI: 10.25121/MR.2018.21.3.281
[6] Foong Way David Tai, Mark E McAlindon, Non-steroidal anti-inflammatory drugs and the gastrointestinal tract https://doi.org/10.7861/clinmed.2021-0039
[7] Dorota Sikorska, Sławomir Chlabicz, Grażyna Rydzewska, Włodzimierz Samborski, Andrzej Tykarski, Jarosław Woroń; Nonsteroidal anti-inflammatory drugs in clinical practice — are there any new reports? ISSN: 2720-3921, e-ISSN: 2720-3913 DOI: 10.5603/rf.99945
[8]C.J. Hawkey; COX-1 and COX-2 inhibitors Author links open overlay panel; DM, FRCP Division of Gastroenterology, University Hospital Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK; Available online 25 May 2002. https://doi.org/10.1053/bega.2001.0236
[9] Tomasz Brzozowski, Peter C. Konturek, Stanislaw J. Konturek, Zbigniew Sliwowski, Robert Pajdo, Danuta Drozdowicz, Agata Ptak, Eckhart G. Hahn; Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers; 09 May 2001; https://doi.org/10.1002/jemt.1102
[10] Wanda Dyr, Metabolism of ethyl alcohol and the development of cancer; DOI: https://doi.org/10.5114/ain.2017.73876
[11] Anderson José Gonzaga Lemos, Simone Pôssas Andrade, Mara Soares de Almeida Mota; Efeitos toxicológicos desencadeados pelo etanol no organismo humano: uma revisão; https://doi.org/10.6008/SPC2236-9600.2017.002.0001
[12] Wojciech Jelski, Barbara Grochowska-Skiba, Maciej Szmitkowski; Alcohol dehydrogenase and the metabolism of ethanol in the brain Postepy Hig Med Dosw, 2007; 61: 226-230 www.phmd.pl e-ISSN 1732-2693,
[13] Aleksandra Kołota The effect of the products of ethanol metabolism on the liver – a review; DOI 10.5114/ain.2018.81664
[14] Adams, W. L. (1995). Interactions between Alcohol and Other Drugs. International Journal of the Addictions, 30(13–14), 1903–1923. https://doi.org/10.3109/10826089509071060
[15] Fraser, AG Pharmacokinetic Interactions Between Alcohol and Other Drugs. Clin. Pharmacokinet. 33 , 79–90 (1997). https://doi.org/10.2165/00003088-199733020-00001,
[16] Wendy L. Adams MD; Potential for Adverse Drug-Alcohol Interactions Among Retirement Community Residents, MPH, September 1995 https://doi.org/10.1111/j.1532-5415.1995.tb05567.x
[17] Ulla Vogel, Jane Christensen, Marianne Dybdahl, Søren Friis, Rikke D. Hansen, Håkan Wallin, Bjørn A. Nexø, Ole Raaschou-Nielsen, Paal S. Andersen, Kim Overvad, Anne Tjønneland; Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer, https://doi.org/10.1016/j.mrfmmm.2007.04.006
[18] Linnoila, M., Mattila, MJ i Kitchell, Drug Interactions With Alcohol;Leki 18 , 299–311 (1979). https://doi.org/10.2165/00003495-197918040-00003
[19] Mattila, M. J. (1990). Alcohol and Drug Interactions. Annals of Medicine, 22(5), 363–369. https://doi.org/10.3109/07853899009147921
[20] Lieber, C. S. (1994). Mechanisms of Ethanol-Drug-Nutrition Interactions. Journal of Toxicology: Clinical Toxicology, 32(6), 631–681. https://doi.org/10.3109/15563659409017974
[21] Włodzimierz Samborski , Dorota Sikorska, Arkadiusz Niklas, Krzysztof J. Filipiak, Jacek Kaczmarczyk , Agnieszka Dobrowolska, Andrzej Tykarski; Non-steroidal anti-inflammatory drugs and cardiovascular and gastroenterological complications: algorithm of choice; DOI: 10.5603/FR.2018.0001
[22] Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health. 1999;23(1):40-54. PMID: 10890797; PMCID: PMC6761694.
[23]Levitt MD, Levitt DG. Use of a two-compartment model to assess the pharmacokinetics of human ethanol metabolism. Alcohol Clin Exp Res. 1998 Nov;22(8):1680-8. PMID: 9835281.
[24] Ghlichloo I, Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613522.
[25] Jadwiga Jośko-Ochojska, Leszek Spandel, Ryszard Brus, Alcohol and tobacco smoke interactions with medications – indispensable everyday knowledge, Hygeia Public Health 2015, 50(3): 474-481
[26] Grosser T, Ricciotti E, FitzGerald GA. The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs. Trends Pharmacol Sci. 2017 Aug;38(8):733-748. doi: 10.1016/j.tips.2017.05.008. Epub 2017 Jun 23. PMID: 28651847; PMCID: PMC5676556.
[27] Patrono C, Baigent C. Nonsteroidal anti-inflammatory drugs and the heart. Circulation. 2014 Feb 25;129(8):907-16. doi: 10.1161/CIRCULATIONAHA.113.004480. PMID: 24566065
[28] Roubille C, Martel-Pelletier J, Davy JM, Haraoui B, Pelletier JP. Cardiovascular adverse effects of anti-inflammatory drugs. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):55-67. doi: 10.2174/1871523011312010008. PMID: 23286294.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kinga Dominiczak, Katarzyna Szafrańska, Adrianna Kopaczyńska, Aleksandra Janiak, Szymon Niemirka, Łukasz Grądalski, Filip Dębicki

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 207
Number of citations: 0